Hasumi Vaccine (ハスミワクチン) — Informational page on a Japanese private-care immunotherapy option
Background information and cross-border coordination support for those considering Hasumi Vaccine. Suitability requires individual physician evaluation; outcomes vary by individual.
We help you communicate with Japanese medical institutions; physicians provide the treatment, we accompany the coordination process.
This page is not medical advertising and does not replace physician advice.
Used clinically in Japan by Hasumi Cancer Research Institute and affiliated institutions
Treatment is delivered by qualified Japanese medical institutions; clinical responsibility rests with the treating institution
Shingihou provides consultation, translation, and scheduling support. We are not a medical provider.
This page is informational only; individual suitability requires physician evaluation.
About Hasumi Vaccine and this site
The Hasumi Vaccine (ハスミワクチン) has been developed and clinically used by the Hasumi family since 1948. In Japan it is a private-care (self-pay) service, not an insured standard therapy. For international patients, the main challenge is often not the treatment itself but the cross-border coordination and information gap — that is where Shingihou exists to help.
This site is operated by Shingihou Co., Ltd. — a cross-border medical coordination support organization. Shingihou is not a medical provider; actual treatment is delivered by qualified Japanese medical institutions such as Hasumi Clinic.
This page is informational only and is not medical advice; it does not replace your treating physician's judgment.
Company registration can be verified via Japan's National Tax Agency "Hojin Bangou Koukyou Saito" (Corporate Number Disclosure Site). This page was last updated: 2026-05.
What we do — and what we don't
To avoid misunderstanding, the boundaries of our coordination support are stated explicitly below.
✅ What we do
- Reply within 1–2 business days from a coordination staff member (not an auto-reply)
- Help organize and translate the medical records you provide (pathology reports, imaging, medication history)
- Forward records to physicians at qualified Japanese medical institutions for review
- Arrange consultation scheduling in Japan, on-site interpretation, and travel coordination
- Act as the communication bridge between the medical side and you during treatment
- Help maintain ongoing contact with the Japanese physician after you return home
❌ What we don't do
- We do not provide medical advice or diagnosis
- We do not answer efficacy questions on behalf of physicians
- We do not guarantee that the Japanese physician will accept your case
- We do not handle legal or financial matters beyond visa-related coordination
- We do not replace your relationship with your primary physician
⚠️ What remains your (and your family's) responsibility
- Providing complete and accurate medical records
- Discussing this option with your primary physician in advance
- Making the decision whether to proceed
- Travel, accommodation, and living expenses during treatment
- Sharing the treatment outcome with your primary physician after returning home
Situations we cannot help with
If you are in an acute medical situation requiring immediate care, this service is not appropriate — please contact your local medical services first. We also do not accept cases that ask us to bypass or hide information from the primary physician.
From inquiry to follow-up
Three phases, five steps. Typically 3–6 weeks from initial inquiry to traveling to Japan, depending on document readiness and physician scheduling.
Phase 1 · Consultation (in your country)
Initial inquiry
Shingihou's coordination staff reviews your needs and current situation, and explains the process.
- Timing
- Reply within 1–2 business days after submission
- Handled by
- Shingihou coordination staff
- You provide
- A brief description of your situation and current treatment (no precise medical terminology needed)
- You receive
- Process explanation, list of required records, and a likely timeline
- Cost
- Free
Medical-side review
Physicians at the medical institution review history, records, and suitability. Possible outcomes: (a) suggested next step, (b) request for additional records, or (c) physician determines the case is not suitable.
- Timing
- Typically 3–5 business days once records are complete
- Handled by
- Physicians at qualified Japanese medical institutions
- You provide
- Pathology reports, imaging records, medication history; we can assist with translation
- You receive
- Physician opinion and recommended next steps
- Cost
- Subject to the medical institution's review fee (itemized in the written estimate)
Phase 2 · Treatment in Japan
Travel to Japan & formulation preparation
You travel to Japan for an in-person consultation and any additional tests; after physician confirmation, the medical institution prepares the individualized formulation. Shingihou arranges interpretation and travel support.
- Timing
- First visit typically requires 3–7 days in Japan (depends on physician plan)
- Handled by
- Medical institution + Shingihou coordination / interpretation
- You provide
- In-person attendance; passport, original medical records, insurance documents (if any)
- You receive
- In-person consultation, formulation preparation, and any required tests
- Cost
- Cost range provided in the written estimate
Administration & on-site observation
The treatment is administered at the medical institution and immediate reactions are observed; any discomfort is managed by the medical staff on the spot.
- Timing
- Same day; observation per physician instruction
- Handled by
- Medical staff at the institution
- You provide
- Pre-treatment preparation as instructed
- You receive
- Post-treatment instructions, medication guidance, and a follow-up plan
- Cost
- Included in treatment fees
Phase 3 · Follow-up after returning home
Follow-up after returning home
After returning home, you can stay in contact with us via email or LINE; if further discussion with the Japanese physician is needed, we help arrange online consultations. Treatment outcomes can be translated for you to share with your primary physician.
- Timing
- Per physician-recommended follow-up interval (typically every 1–3 months)
- Handled by
- Shingihou coordination + liaison with Japanese physician as needed
- You provide
- Status updates after returning home; regular sharing with your primary physician
- You receive
- Communication support with the Japanese physician; translation of treatment outcomes
- Cost
- Online consultation fees are charged separately; translation fees depend on volume
Suitability / Precautions
Situations you may discuss with your physician
- Post-operative patients evaluating long-term care options
- Those currently receiving chemotherapy/radiation/targeted therapy who wish to discuss complementary options
- Those interested in immunotherapy options who have consulted their primary physician
- Those wishing to discuss quality-of-life aspects of long-term care
Situations likely not suitable
- Patients with severe immune system disorders
- During acute infection periods
- Pregnant or breastfeeding women
- Those with specific allergies (physician evaluation required)
All suitability must be individually assessed by qualified physicians. We recommend confirming with your primary physician and seeking a second opinion when needed.
Potential risks / Adverse reactions
Common injection reactions and precautions
- Redness or discomfort at the injection site
- Mild fever
- Fatigue
- Muscle or joint pain
Seek medical attention immediately if symptoms occur. Individual reactions vary; follow your physician's instructions.
Conceptual mechanism overview
A conceptual illustration based on immunological research hypotheses — not a guarantee of clinical effect
This section is a research-based conceptual illustration. You do not need to understand any of it to begin a consultation — it is provided for readers who wish to know more. Clinical outcomes vary by individual and require physician evaluation.
Antigen recognition
Research suggests specific antigens may help the immune system identify target cells
Immune activation
Research has observed activation of immune responses such as T cells and NK cells
Immune response
Conceptual illustration of the immune system responding to research-defined target cells
Ongoing monitoring
Continuous observation of immune response and overall condition as part of long-term follow-up
Aspects to discuss with your physician
In a consultation, the physician will typically discuss the following aspects with you. These are not guarantees of efficacy; individual variation is significant.
Compatibility and scheduling alongside standard treatment
An outpatient procedure with relatively low invasiveness
Quality-of-life (QOL) aspects of long-term care
Formulation tailored to individual case
A long-term follow-up–oriented treatment requiring regular visits
The above are discussion points, not guarantees of clinical effect. Suitability requires individual physician evaluation.
References
Links to relevant organizations for background reference only
This site does not cite third-party literature as endorsement of efficacy. For research materials, please contact Hasumi Clinic or the Hasumi International Research Foundation directly.
參考組織 / Reference Organizations
Fee structure
In Japan, Hasumi Vaccine is private care / self-pay and is generally not covered by health insurance.
Actual amounts vary by individual case, treatment frequency, and formulation. We provide a written estimate after the initial review rather than an on-the-spot quote.
What fees typically include
- Initial consultation and suitability assessment
- Necessary tests and pathology review
- Individualized formulation preparation
- Administration and immediate observation
- Regular follow-up over the treatment period
- Cross-border coordination (translation, scheduling, documentation support)
We provide fee-structure transparency rather than a fixed price, because actual amounts must be determined after individual review.
Cancellation & refunds
If the physician determines during the review phase that the case is not suitable, only the actually-incurred review fee is charged; no subsequent treatment fees apply. Cases already in progress are handled by individual agreement. Travel and accommodation expenses cannot be reimbursed.
Frequently asked questions
Contact / Inquiry request
Please fill in the form. Coordination staff typically reply within 1–2 business days (Japan business days 9:00–18:00; national holidays may delay).
After you submit the form
- 1A coordination staff member (not an auto-reply) will respond
- 2You typically receive the first reply within 1–2 business days
- 3The reply will include a list of required records, a likely timeline, and the next steps
If you have not received a reply within 3 business days, please write directly to service@shingihou.com.
Disclaimer / Regulatory disclosure
⚠️ This page is informational only and is not medical advice.
- Shingihou Co., Ltd. is a cross-border medical coordination support organization, not a medical provider; treatment is delivered by qualified Japanese medical institutions
- Hasumi Vaccine in Japan is private care / not insured; outcomes vary by individual and no efficacy is guaranteed
- Consult your primary physician before considering any therapy; information on this site does not establish a doctor-patient relationship